EPRS

EPIRUS BIOPHARMACEUTICALS INC COM
EPRS

Overview Fund Activity
Delisted

EPRS was delisted on the 3rd of August, 2016.

Back to rankings

41 hedge funds and large institutions have $81M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
9
Closed
14
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$12.9M
2
B
2
Bailard
California
$1.41M
3
BFA
3
BlackRock Fund Advisors
California
$242K
4
Citadel Advisors
4
Citadel Advisors
Florida
$230K
5
Millennium Management
5
Millennium Management
New York
$527K

Top Sellers

1
FM
1
Forward Management
California
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$0
3
TI
3
Trexquant Investment
Connecticut
$0
4
CAD
4
Craig A. Drill
$0
5
LOAMU
5
Lombard Odier Asset Management (USA)
New York
$724K
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
51
Deutsche Bank
Germany
– -$54K -6,056 Closed
Creative Planning
52
Creative Planning
Kansas
– -$4K -433 Closed
TRCT
53
Tower Research Capital (TRC)
New York
– -$3K -333 Closed
1 2
3